These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34572926)

  • 1. Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression.
    Fukano M; Park M; Deblois G
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining a metabolic landscape of tumours: genome meets metabolism.
    Seth Nanda C; Venkateswaran SV; Patani N; Yuneva M
    Br J Cancer; 2020 Jan; 122(2):136-149. PubMed ID: 31819196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic regulation of prostate cancer heterogeneity and plasticity.
    Peitzsch C; Gorodetska I; Klusa D; Shi Q; Alves TC; Pantel K; Dubrovska A
    Semin Cancer Biol; 2022 Jul; 82():94-119. PubMed ID: 33290846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression.
    Lüönd F; Tiede S; Christofori G
    Br J Cancer; 2021 Jul; 125(2):164-175. PubMed ID: 33824479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
    Pacella I; Piconese S
    Front Immunol; 2019; 10():1889. PubMed ID: 31507585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism in the Tumour-Bone Microenvironment.
    Whitburn J; Edwards CM
    Curr Osteoporos Rep; 2021 Oct; 19(5):494-499. PubMed ID: 34319488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity.
    Avagliano A; Ruocco MR; Aliotta F; Belviso I; Accurso A; Masone S; Montagnani S; Arcucci A
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer metabolism: a therapeutic perspective.
    Martinez-Outschoorn UE; Peiris-Pagés M; Pestell RG; Sotgia F; Lisanti MP
    Nat Rev Clin Oncol; 2017 Jan; 14(1):11-31. PubMed ID: 27141887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take.
    Altea-Manzano P; Cuadros AM; Broadfield LA; Fendt SM
    EMBO Rep; 2020 Oct; 21(10):e50635. PubMed ID: 32964587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour Microenvironment-Immune Cell Interactions Influencing Breast Cancer Heterogeneity and Disease Progression.
    Tan K; Naylor MJ
    Front Oncol; 2022; 12():876451. PubMed ID: 35646658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review.
    Kobayashi H
    Heliyon; 2022 Nov; 8(11):e11487. PubMed ID: 36406733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields.
    Beyes S; Bediaga NG; Zippo A
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proline Metabolism in Tumor Growth and Metastatic Progression.
    D'Aniello C; Patriarca EJ; Phang JM; Minchiotti G
    Front Oncol; 2020; 10():776. PubMed ID: 32500033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
    El Ansari R; McIntyre A; Craze ML; Ellis IO; Rakha EA; Green AR
    Histopathology; 2018 Jan; 72(2):183-190. PubMed ID: 28771772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connecting Metabolic Rewiring With Phenotype Switching in Melanoma.
    Falletta P; Goding CR; Vivas-García Y
    Front Cell Dev Biol; 2022; 10():930250. PubMed ID: 35912100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cancer metabolism on therapy resistance - Clinical implications.
    Gonçalves AC; Richiardone E; Jorge J; Polónia B; Xavier CPR; Salaroglio IC; Riganti C; Vasconcelos MH; Corbet C; Sarmento-Ribeiro AB
    Drug Resist Updat; 2021 Dec; 59():100797. PubMed ID: 34955385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy.
    Petővári G; Dankó T; Tőkés AM; Vetlényi E; Krencz I; Raffay R; Hajdu M; Sztankovics D; Németh K; Vellai-Takács K; Jeney A; Kulka J; Sebestyén A
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.
    Correnti M; Binatti E; Gammella E; Invernizzi P; Recalcati S
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.